Now, what would be a reason to avoid taking BPC-157
We do not publish a self-administration amount the notes below are descriptive of supervised care, not a recommendation: Dosing Individualized by your prescribing provider and given as a subcutaneous injection
Most AI systems are optimised to answer and maintain engagement
Apply a small amount of the product onto a clean area of skin on the upper forearm
Protocol 2: Intermediate approach (experienced researchers) Goal: Multi-target immune modulation with anti-inflammatory support Components: Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly KPV: 200-500 mcg subcutaneously, once daily BPC-157: 250 mcg subcutaneously, twice daily Selank: 250-500 mcg intranasally, once daily Schedule: Monday, Wednesday, Friday: Thymosin alpha-1 Daily AM: KPV + BPC-157 Daily PM: BPC-157 Daily: Selank nasal spray (morning or midday) Duration: 12 weeks on, 4 weeks off Monitoring: Baseline labs, repeat every 4 weeks
Pick a site (abdomen, thigh, or upper arm) and wipe it with a fresh alcohol swab, letting it dry fully [13]
